<DOC>
	<DOCNO>NCT02174822</DOCNO>
	<brief_summary>To assess steady state pharmacokinetics ( PK ) , safety tolerability AVP-786 ( deuterated [ d6 ] dextromethorphan hydrobromide [ DM ] /quinidine sulfate [ Q ] ) paroxetine AVP-786 duloxetine .</brief_summary>
	<brief_title>A Phase 1 , Drug Interaction Study Between AVP-786 Paroxetine Between AVP-786 Duloxetine Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Quinidine</mesh_term>
	<criteria>Healthy adult male females 18 50 year age BMI 18 30 kg/m2 History presence significant disease History substance abuse and/or alcohol abuse past 3 year Use tobaccocontaining nicotinecontaining product within 6 month Use prescription overthecounter medication within 14 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Drug-drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>deuterated dextromethorphan</keyword>
	<keyword>deuterated dextromethorphan quinidine</keyword>
</DOC>